Chronicle Bio, Inc.
Biotech · Series B · Regulation D 506(b) · CA · Filed July 7, 2026
- Offering amount
- $15.0M
- Exemption
- Reg D 506(b)
- Issuer state
- CA
- Filing date
- July 7, 2026
- Signature date
- July 6, 2026
- CIK
- 0002090889
What is a Form D filing?
A Form D is the notice a private company files with the U.S. Securities and Exchange Commission when raising capital through an offering exempt under Regulation D (Rule 506(b), 506(c), or 504). It discloses the offering but is not a solicitation, an endorsement, or a statement of investment merit. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Public filing directories
Browse directories that group public SEC Form D records by the same filing tags shown on this page. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Summary
Auto-generatedChronicle Bio, Inc. is a biotech operating company based on 'Bio' in name. $15M offering under 506(b) anchors series-b stage.
Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Source
FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.